Key result
Two novel heterozygous Nkx2.5 mutations were identified in 1.47% of patients with idiopathic atrial fibrillation and were absent in healthy controls.
Why the study?
Are Nkx2.5 mutations associated with idiopathic atrial fibrillation?
Case-Control (n=336)
Are Nkx2.5 mutations associated with idiopathic atrial fibrillation?
Absolute Event Rate: 1.47% vs 0%
Nkx2.5 loss-of-function mutations are present in a small subset of patients with idiopathic atrial fibrillation and may contribute to its molecular pathogenesis.
Nkx2.5 mutations may underlie idiopathic AF in a small subset; leaves open whether genetic screening alters management or risk stratification.
OBJECTIVE: The aim of this study was to evaluate the prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation (AF). METHODS: A cohort of 136 unrelated patients with idiopathic atrial fibrillation and 200 unrelated, ethnically matched healthy controls were enrolled. The coding exons and splice junctions of the Nkx2.5 gene were sequenced in 136 atrial fibrillation patients, and the available relatives of mutation carriers and 200 controls were subsequently genotyped for the identified mutations. The functional characteristics of the mutated Nkx2.5 gene were analyzed using a dual-luciferase reporter assay system. RESULTS: Two novel heterozygous Nkx2.5 mutations (p.N19D and p.F186S) were identified in 2 of the 136 unrelated atrial fibrillation cases, with a mutational prevalence of approximately 1.47%. These missense mutations co-segregated with atrial fibrillation in the families and were absent in the 400 control chromosomes. Notably, 2 mutation carriers also had congenital atrial septal defects and atrioventricular block. Multiple alignments of the Nkx2.5 protein sequences across various species revealed that the altered amino acids were completely conserved evolutionarily. Functional analysis demonstrated that the mutant Nkx2.5 proteins were associated with significantly reduced transcriptional activity compared to their wild-type counterpart. CONCLUSION: These findings associate the Nkx2.5 loss-of-function mutation with atrial fibrillation and atrioventricular block and provide novel insights into the molecular mechanism involved in the pathogenesis of atrial fibrillation. These results also have potential implications for early prophylaxis and allele-specific therapy of this common arrhythmia.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2013) conducted a case-control in Idiopathic atrial fibrillation (n=336). Nkx2.5 mutations vs. Healthy controls was evaluated on Prevalence of Nkx2.5 mutations. Two novel heterozygous Nkx2.5 mutations were identified in 1.47% of patients with idiopathic atrial fibrillation and were absent in healthy controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: